Summit Therapeutics (SMMT) Amortizatization of Intangibles (2016 - 2026)
Summit Therapeutics filings provide 13 years of Amortizatization of Intangibles readings, the most recent being $4.2 million for Q1 2026.
- Quarterly Amortizatization of Intangibles rose 42.18% to $4.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $8.3 million through Mar 2026, up 60.64% year-over-year, with the annual reading at $7.0 million for FY2025, 171.97% up from the prior year.
- Amortizatization of Intangibles hit $4.2 million in Q1 2026 for Summit Therapeutics, up from $3.0 million in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $4.2 million in Q1 2026 and bottomed at -$2.4 million in Q4 2024.
- Average Amortizatization of Intangibles over 5 years is $1.1 million, with a median of $402000.0 recorded in 2024.
- The largest annual shift saw Amortizatization of Intangibles plummeted 1229.81% in 2024 before it soared 637.81% in 2025.
- Summit Therapeutics' Amortizatization of Intangibles stood at -$960000.0 in 2022, then surged by 121.67% to $208000.0 in 2023, then plummeted by 1229.81% to -$2.4 million in 2024, then surged by 228.38% to $3.0 million in 2025, then skyrocketed by 39.77% to $4.2 million in 2026.
- Per Business Quant, the three most recent readings for SMMT's Amortizatization of Intangibles are $4.2 million (Q1 2026), $3.0 million (Q4 2025), and $1.0 million (Q2 2025).